Antigen-specific in vitro suppression of murine Helicobacter pylori-reactive immunopathological T cells by CD4+CD25+ regulatory T cells

被引:67
作者
Raghavan, S
Suri-Payer, E
Holmgren, J
机构
[1] Univ Gothenburg, Dept Med Microbiol & Immunol, S-40530 Gothenburg, Sweden
[2] Univ Gothenburg, Vaccine Res Inst GUVAX, S-40530 Gothenburg, Sweden
[3] German Canc Res Ctr, Dept Tumor Immunol, Heidelberg, Vic, Australia
关键词
D O I
10.1111/j.0300-9475.2004.01447.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A Helicobacter pylori-specific in vitro coculture system was established and used to study the role of CD4(+)CD25(+) regulatory T cells (Treg) in gastritis development in mice with H. pylori infection. Effects of therapeutic immunization against H. pylori infection on the Treg function were also studied to better understand the mechanisms leading to postimmunization gastritis in these mice. Depletion of Treg led to extensive proliferation to H. pylori antigens of CD4(+) T cells isolated from either naive, H. pylori-infected or H. pylori-immunized mice. Using the Treg-depleted CD4(+) T cells from immunized mice as effector cells, we compared the suppressive efficacy of Treg isolated from naive, infected or immunized mice and found that Treg from naive mice, and slightly less efficiently from infected mice, suppressed the CD25(-) effector T-cell response and in most cases were distinctly more efficacious than Treg isolated from immunized mice. The suppressive efficacy of Treg isolated from the differently treated mice correlated closely with production of interleukin-5 (IL-5) by the Treg and suppression of interferon-gamma and IL-2 production by the CD25(-) effector T cells. Our study is the first to demonstrate in H. pylori-induced chronic infection, antigen-specific Treg with differential efficacy in suppressing H. pylori proinflammatory T effector cells.
引用
收藏
页码:82 / 88
页数:7
相关论文
共 29 条
[21]   Effects of oral vaccination and immunomodulation by cholera toxin on experimental Helicobacter pylori infection, reinfection, and gastritis [J].
Raghavan, S ;
Svennerholm, AM ;
Holmgren, J .
INFECTION AND IMMUNITY, 2002, 70 (08) :4621-4627
[22]   Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells:: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance [J].
Sakaguchi, S ;
Sakaguchi, N ;
Shimizu, J ;
Yamazaki, S ;
Sakihama, T ;
Itoh, M ;
Kuniyasu, Y ;
Nomura, T ;
Toda, M ;
Takahashi, T .
IMMUNOLOGICAL REVIEWS, 2001, 182 :18-32
[23]   Control of intestinal inflammation by regulatory T cells [J].
Singh, B ;
Read, S ;
Asseman, C ;
Malmström, V ;
Mottet, C ;
Stephens, LA ;
Stepankova, R ;
Tlaskalova, H ;
Powrie, F .
IMMUNOLOGICAL REVIEWS, 2001, 182 :190-200
[24]  
Stephens LA, 2001, EUR J IMMUNOL, V31, P1247, DOI 10.1002/1521-4141(200104)31:4<1247::AID-IMMU1247>3.0.CO
[25]  
2-M
[26]  
Suri-Payer E, 1998, J IMMUNOL, V160, P1212
[27]   Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells:: induction of autoimmune disease by breaking their anergic/suppressive state [J].
Takahashi, T ;
Kuniyasu, Y ;
Toda, M ;
Sakaguchi, N ;
Itoh, M ;
Iwata, M ;
Shimizu, J ;
Sakaguchi, S .
INTERNATIONAL IMMUNOLOGY, 1998, 10 (12) :1969-1980
[28]   CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production [J].
Thornton, AM ;
Shevach, EM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (02) :287-296
[29]   Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood [J].
Wing, K ;
Ekmark, A ;
Karlsson, H ;
Rudin, A ;
Suri-Payer, E .
IMMUNOLOGY, 2002, 106 (02) :190-199